Home

News

Justin Turner QC joins 8 New Square20 June 2022Justin Turner QC, a leading advocate and IP specialist with a particular interest in pharmaceutical and biotech cases, will be joining 8 New Square on 20th June 2022. Members of chambers have worked with Justin for many years and are delighted to welcome him following his decision to move from his previous chambers. Justin has appeared in many of the leading cases at all […]
Managing IP Awards 202215 June 20228 New Square’s Jaani Riordan won the UK Junior IP Barrister of the Year award at this year’s Managing IP Awards, with Isabel Jamal also being nominated in this category. Daniel Alexander QC, Adrian Speck QC, Andrew Lykiardopoulos QC, Charlotte May QC, James Abrahams QC and Lindsay Lane QC were all nominated in the Senior […]
Shazam v Only Fools The Dining Experience [2022] EWHC 1379 (IPEC)8 June 2022Shazam, the company holding the rights in the sitcom Only Fools and Horses previously owned by its creator, John Sullivan, sued Only Fools The Dining Experience (‘OFDE’) and related companies and individuals for using characters, catchphrases, themes and other material taken from the sitcom in their immersive theatrical dining experience “Only Fools The (cushty) Dining […]
Advanced Bionics AG & Anr v Med-El Elektromedizinische Geräte Gmbh [2022] EWHC 1345 (Pat)1 June 2022Andrew Lykiardopoulos QC appeared as lead counsel for the claimants (“Advanced Bionics”) in proceedings brought against the defendant (“Med-El”) to revoke a patent relating to MRI-safe disk magnets and/or a declaration that Advanced Bionics’ implant device did not infringe.  Med-El counterclaimed for infringement, with the proceedings conducted through the Shorter Trials Scheme. The trial in […]
Saint-Gobain Adfors SAS v 3M Innovative Properties Co [2022] EWHC 1018 (Pat)9 May 2022James Abrahams QC and Michael Conway successfully appeared for the claimant (“Saint-Gobain”) in a claim to revoke a European patent (“the Patent”) registered by the defendant (“3M”) for dish-shaped abrasive particles with a recessed surface. The Patent claimed that dish-shaped abrasive particles, with a sloping sidewall and a specific thickness ratio, increase the grinding performance […]
Neurim Pharmaceuticals (1991) Ltd & Anr v Teva UK Ltd [2022] EWHC 954 (Pat)26 April 2022Charlotte May QC successfully appeared as lead counsel for the defendant (“Teva”) in opposing an application for an interim injunction brought by the claimants (“Neurim”) for an order restraining Teva from disposing of, offering for sale, selling or supplying a generic version of Circadin. The hearing of the application had been expedited by Roth J. […]
Alcon Eye Care UK Ltd & Anr v AMO Development LLC [2022] EWHC 955 (Pat)26 April 2022Michael Tappin QC and Henry Ward appeared for the defendant and patentee (“AMO”) in legal proceeding brought by the claimants (“Alcon”) to revoke two patents for ophthalmic surgical systems used for carrying out cataract surgery.  Alcon’s validity attack was based on obviousness and insufficiency.  AMO counterclaimed for infringement of the patents by Alcon’s LenSx laser […]
Lewis Silkin Podcast – FYIP: Diversity in the Legal Profession with 8 New Square’s Ashton Chantrielle21 April 2022This month, Stephanie Kay and Antony Craggs from Lewis Silkin interviewed Ashton Chantrielle.  Ashton discussed her process of becoming a Barrister and some of her recent cases, as well as diversity in the profession. Please click here to listen to the podcast.
easyGroup Ltd -v- Nuclei Ltd (t/a Easy Offices) & Ors [2022] EWHC 901 (Ch)13 April 2022Jaani Riordan successfully appeared as junior counsel led by Mark Vanhegan QC for the defendants (collectively, “Nuclei”) in proceedings brought by the claimant (“easyGroup”) alleging infringement of four EU and UK trade marks for EASYOFFICE in various forms (“the Trade Marks”).  The Trade Marks were registered in relation to services including hire and rental of […]
Sandoz Ltd & Ors v Bristol-Myers Squibb Holdings [2022] EWHC 822 (Pat)7 April 2022Michael Tappin QC appeared as lead counsel for Sandoz in proceedings brought with Teva to revoke a patent owned by Bristol-Myers Squibb (“BMS”).  BMS counterclaimed for infringement, which, in the event that the patent was found to be valid, Sandoz and Teva admitted. The patent related to the compound apixaban sold by BMS under the […]